An intensive treatment approach to lowering high systolic blood pressure in people with Type 2 diabetes led to a reduced risk ...

People living with type 2 diabetes face several significant health challenges. The condition, which affects more than 10% of ...

IDF creating new Type 2 diabetes guidelines with global experts, focusing on patient-centered care and global accessibility.

Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...

Reducing systolic blood pressure to less than 120 mmHg lowered the risk of major cardiovascular events for most people with ...

The AYUSH ministry aims to combine traditional and modern medicine in order to make treatments more effective and improve ...

Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China ...

Spanning 176 weeks of treatment, the Phase III trial evaluated the efficacy and safety of tirzepatide in adults without type ...

Global diabetes rates quadrupled since 1990, affecting 828 million adults, with treatment disparities persisting.

For patients with diabetes, a systolic target of 120 mm Hg led to a significant reduction in CV events in BPROADS, mirroring ...

Findings from a 3-year analysis demonstrated that among patients treated with tirzepatide, 98.8% remained diabetes free.

The total number of adults living with either type 1 or type 2 diabetes in the world has surpassed 800 million—over four ...